Precigen (PGEN) Other Operating Expenses (2013 - 2026)
Precigen (PGEN) posted quarterly Other Operating Expenses of $2.6 million for Q1 2026, up 132.64% year-over-year from $1.1 million in Q1 2025, and up 60.34% quarter-over-quarter from $1.6 million in Q4 2025.
Analysis
Precigen (PGEN) Other Operating Expenses (2013 - 2026) Analysis & Trends
Precigen (PGEN) has reported Other Operating Expenses for 15 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 132.64% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $10.2 million (down 77.16% YoY), while the FY2025 annual figure was $8.7 million, down 80.42% from the prior year.
- Other Operating Expenses advanced to $2.6 million in Q1 2026 per PGEN's latest filing, from $1.6 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $35.6 million in Q2 2024 and bottomed at $1.0 million in Q3 2024.
- Historically, Other Operating Expenses has averaged $4.7 million across 5 years, with a median of $1.6 million in 2025.
- Annual changes were most pronounced in 2024 — Other Operating Expenses soared 1995.4% — and 2025, when it tumbled 85.94%.
- Precigen's Other Operating Expenses stood at $1.3 million in 2022, then jumped by 870.01% to $12.2 million in 2023, then tumbled by 43.02% to $6.9 million in 2024, then tumbled by 77.03% to $1.6 million in 2025, then soared by 60.34% to $2.6 million in 2026.
- Business Quant data shows PGEN's Other Operating Expenses at $2.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.81 Mn |
| Mar 31, 2026 | 2.56 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 35.56 Mn |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 12.19 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Sep 30, 2021 | 1.45 Mn |